DK0684825T3 - Fremgangsmåde til forebyggelse eller inhibering af befrugtning - Google Patents

Fremgangsmåde til forebyggelse eller inhibering af befrugtning

Info

Publication number
DK0684825T3
DK0684825T3 DK94910707T DK94910707T DK0684825T3 DK 0684825 T3 DK0684825 T3 DK 0684825T3 DK 94910707 T DK94910707 T DK 94910707T DK 94910707 T DK94910707 T DK 94910707T DK 0684825 T3 DK0684825 T3 DK 0684825T3
Authority
DK
Denmark
Prior art keywords
preventing
inhibiting fertilization
fertilization
inhibiting
oocyte
Prior art date
Application number
DK94910707T
Other languages
English (en)
Inventor
Gary D Hodgen
Original Assignee
Hampton Roads Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hampton Roads Medical College filed Critical Hampton Roads Medical College
Application granted granted Critical
Publication of DK0684825T3 publication Critical patent/DK0684825T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catching Or Destruction (AREA)
  • Pens And Brushes (AREA)
  • Steroid Compounds (AREA)
  • Fertilizers (AREA)
  • Fats And Perfumes (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK94910707T 1993-02-19 1994-02-18 Fremgangsmåde til forebyggelse eller inhibering af befrugtning DK0684825T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/019,791 US5516769A (en) 1993-02-19 1993-02-19 Method of inhibiting fertilization
PCT/US1994/001804 WO1994018982A1 (en) 1993-02-19 1994-02-18 Method of preventing or inhibiting fertilization

Publications (1)

Publication Number Publication Date
DK0684825T3 true DK0684825T3 (da) 2002-07-15

Family

ID=21795040

Family Applications (2)

Application Number Title Priority Date Filing Date
DK01117955T DK1159965T3 (da) 1993-02-19 1994-02-18 Anvendelse af en progesteronreceptor-antagonist til forebyggelse eller inhibering af befrugtning
DK94910707T DK0684825T3 (da) 1993-02-19 1994-02-18 Fremgangsmåde til forebyggelse eller inhibering af befrugtning

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK01117955T DK1159965T3 (da) 1993-02-19 1994-02-18 Anvendelse af en progesteronreceptor-antagonist til forebyggelse eller inhibering af befrugtning

Country Status (24)

Country Link
US (1) US5516769A (da)
EP (2) EP1159965B1 (da)
JP (1) JP3054780B2 (da)
KR (1) KR100232833B1 (da)
AT (2) ATE286734T1 (da)
AU (1) AU692150B2 (da)
BG (1) BG62431B1 (da)
BR (1) BR9406666A (da)
CA (1) CA2156493C (da)
CZ (1) CZ294325B6 (da)
DE (2) DE69434239T2 (da)
DK (2) DK1159965T3 (da)
ES (1) ES2231356T3 (da)
FI (1) FI114687B (da)
HU (1) HU221162B1 (da)
NO (1) NO307916B1 (da)
NZ (1) NZ262998A (da)
PL (1) PL175440B1 (da)
PT (2) PT684825E (da)
RO (1) RO118565B1 (da)
RU (1) RU2139055C1 (da)
SK (1) SK282068B6 (da)
UA (1) UA41351C2 (da)
WO (1) WO1994018982A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US7704983B1 (en) 1992-03-02 2010-04-27 Eastern Virginia Medical School Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
CO5190694A1 (es) 1999-08-31 2002-08-29 Jenapharm Gmbh And Co Kg Mesoprogestinas (moduladores de receptores de progesterona) como componentes de anticonceptivos femeninos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890356A (en) * 1973-03-26 1975-06-17 Richardson Merrell Inc 7-Alkyl-{66 {hu 3,5{b -steroids
US3928398A (en) * 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4000273A (en) * 1973-11-01 1976-12-28 Richardson-Merrell Inc. Method for the control of fertility
US4416822A (en) * 1982-07-09 1983-11-22 The Upjohn Company 17β-Difluoromethyl steroids
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives

Also Published As

Publication number Publication date
UA41351C2 (uk) 2001-09-17
CA2156493C (en) 2002-10-29
BR9406666A (pt) 1996-01-23
NO953242D0 (no) 1995-08-17
BG62431B1 (bg) 1999-11-30
CA2156493A1 (en) 1994-09-01
DE69434239D1 (de) 2005-02-17
DE69434239T2 (de) 2006-03-30
DE69430732D1 (de) 2002-07-11
PT1159965E (pt) 2005-03-31
NZ262998A (en) 1997-06-24
CZ205095A3 (en) 1996-01-17
BG99867A (bg) 1996-04-30
EP1159965A3 (en) 2002-05-22
KR960700726A (ko) 1996-02-24
HUT72079A (en) 1996-03-28
PL175440B1 (pl) 1998-12-31
DE69430732T2 (de) 2002-10-24
AU6299294A (en) 1994-09-14
RU2139055C1 (ru) 1999-10-10
SK282068B6 (sk) 2001-10-08
FI114687B (fi) 2004-12-15
HU221162B1 (en) 2002-08-28
ES2231356T3 (es) 2005-05-16
DK1159965T3 (da) 2005-05-23
CZ294325B6 (cs) 2004-11-10
PT684825E (pt) 2002-10-31
NO953242L (no) 1995-08-17
EP1159965B1 (en) 2005-01-12
FI953878A (fi) 1995-08-17
KR100232833B1 (ko) 1999-12-01
SK101395A3 (en) 1997-04-09
FI953878A0 (fi) 1995-08-17
JPH08510992A (ja) 1996-11-19
ATE286734T1 (de) 2005-01-15
EP0684825B1 (en) 2002-06-05
RO118565B1 (ro) 2003-07-30
JP3054780B2 (ja) 2000-06-19
EP1159965A2 (en) 2001-12-05
ATE218347T1 (de) 2002-06-15
EP0684825A4 (en) 1998-01-14
NO307916B1 (no) 2000-06-19
EP0684825A1 (en) 1995-12-06
AU692150B2 (en) 1998-06-04
WO1994018982A1 (en) 1994-09-01
PL310357A1 (en) 1995-12-11
US5516769A (en) 1996-05-14

Similar Documents

Publication Publication Date Title
FR2656521B1 (fr) Procede et dispositif pour melanger et administrer directement au point d'application un ciment osseux constitue de deux composes.
BR9408246A (pt) Composto derivado de 3-azabicicloalcano N-substituído
ATE236115T1 (de) Dimer-selektive rxr modulatoren und verfahren zu ihrer verwendung
ES2132339T3 (es) Derivados sulfonato y carbamato de los 3-aroilbenzo(beta)tiofenos.
DK0631810T3 (da) Apparat til at blande og on-line detektere homogenitet
ES2114605T5 (es) Metodo anticonceptivo que emplea un antagonista de progesterona competitivo y nuevos compuestos utilizados en el.
MX9801890A (es) Nuevos compuestos antagonistas selectivos del receptor nk3 humano, procedimiento para su obtencion y composiciones farmaceuticas que los contienen.
DE69425655T2 (de) Antagonisten des fibrinogenrezeptors
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
ES2081636T3 (es) Preparacion de piperidinas sustituidas.
DK0684825T3 (da) Fremgangsmåde til forebyggelse eller inhibering af befrugtning
DK16783D0 (da) Fremgangsmade til fremstilling af 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinoner
BE867478A (fr) Dispositif de fixation par les bouts, d'elements de constructions tels que les tubes
JPS53114431A (en) Powder developing system
KR970061245A (ko) 프로제스테론 및 에스트로젠 작동약을 사용한, 뼈 손실 예방용 약학 조성물
EA199700045A1 (ru) ЭПИМЕРЫ (22RS)-N-(1,1,1-ТРИФТОР-2-ФЕНИЛПРОП-2-ИЛ)-3-ОКСО-4-АЗА-5α-АНДРОСТ-1-ЕН-17β-КАРБОКСАМИДА
AU3024289A (en) The use of monoclonal antibodies (mabs) as procedure control for immunometric assays
JPS5421976A (en) Liquid crystal material
MX9301546A (es) Preparado farmaceutico que contiene un canal activador de potasio y un receptor antagonista de la angiotensina ii y proceso para la fabricacion de tal preparado
KR900019574U (ko) 투사 tv용 집광 보강 장치
BR9714883A (pt) Composição para tratamento do cabelo